Download Citation
Article Source:
Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade
Do A,
Mittal Y,
Liapakis A,
Cohen E,
Chau H,
et al.
(2015)
Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade.
PLOS ONE 10(8): e0135645.
https://doi.org/10.1371/journal.pone.0135645